CN116083329A - Method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation - Google Patents
Method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation Download PDFInfo
- Publication number
- CN116083329A CN116083329A CN202211176997.7A CN202211176997A CN116083329A CN 116083329 A CN116083329 A CN 116083329A CN 202211176997 A CN202211176997 A CN 202211176997A CN 116083329 A CN116083329 A CN 116083329A
- Authority
- CN
- China
- Prior art keywords
- gene
- seq
- corynebacterium glutamicum
- fermentation
- yqhd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 title claims abstract description 65
- 238000000855 fermentation Methods 0.000 title claims abstract description 46
- 230000004151 fermentation Effects 0.000 title claims abstract description 46
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title abstract description 23
- 241000186226 Corynebacterium glutamicum Species 0.000 claims abstract description 36
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 19
- 239000008103 glucose Substances 0.000 claims abstract description 19
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 17
- 229930006000 Sucrose Natural products 0.000 claims abstract description 17
- 239000005720 sucrose Substances 0.000 claims abstract description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 16
- 108091022930 Glutamate decarboxylase Proteins 0.000 claims abstract description 13
- 101100098786 Bacillus subtilis (strain 168) tapA gene Proteins 0.000 claims abstract description 11
- 101100321116 Escherichia coli (strain K12) yqhD gene Proteins 0.000 claims abstract description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 11
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims abstract description 10
- 101150116670 gabT gene Proteins 0.000 claims abstract description 10
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 10
- 108090000340 Transaminases Proteins 0.000 claims abstract description 9
- 101150058049 car gene Proteins 0.000 claims abstract description 8
- 108010001814 phosphopantetheinyl transferase Proteins 0.000 claims abstract description 8
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims abstract description 7
- 101150118940 gadB gene Proteins 0.000 claims abstract description 7
- 102000008214 Glutamate decarboxylase Human genes 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- 241001508003 Mycobacterium abscessus Species 0.000 claims description 3
- 241000187492 Mycobacterium marinum Species 0.000 claims description 3
- 241001197104 Nocardia iowensis Species 0.000 claims description 3
- 238000012262 fermentative production Methods 0.000 claims description 3
- 101100335876 Escherichia coli (strain K12) galT gene Proteins 0.000 claims description 2
- 241000589776 Pseudomonas putida Species 0.000 claims description 2
- 101100121086 Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440) galB gene Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 239000007858 starting material Substances 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 12
- 244000005700 microbiome Species 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 9
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 abstract description 6
- 229940006015 4-hydroxybutyric acid Drugs 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 230000000911 decarboxylating effect Effects 0.000 abstract description 2
- 239000012634 fragment Substances 0.000 description 16
- 239000013612 plasmid Substances 0.000 description 12
- 150000001413 amino acids Chemical group 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 235000013379 molasses Nutrition 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- 241000759360 Corynebacterium glutamicum S9114 Species 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920002961 polybutylene succinate Polymers 0.000 description 3
- 239000004631 polybutylene succinate Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 101150063416 add gene Proteins 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- -1 polybutylene terephthalate Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920001896 polybutyrate Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 2
- 239000011747 thiamine hydrochloride Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 101710124383 Alcohol dehydrogenase YqhD Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 239000005997 Calcium carbide Substances 0.000 description 1
- 101100010747 Escherichia coli (strain K12) epd gene Proteins 0.000 description 1
- 101150098454 GAPA2 gene Proteins 0.000 description 1
- 101150036652 GAPB gene Proteins 0.000 description 1
- 101100335749 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) gap gene Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 101000794816 Pseudomonas putida Anthranilate synthase component 1 Proteins 0.000 description 1
- 101000847784 Pseudomonas putida Anthranilate synthase component 2 Proteins 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- CLZWAWBPWVRRGI-UHFFFAOYSA-N tert-butyl 2-[2-[2-[2-[bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]-5-bromophenoxy]ethoxy]-4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]anilino]acetate Chemical compound CC1=CC=C(N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)C(OCCOC=2C(=CC=C(Br)C=2)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)=C1 CLZWAWBPWVRRGI-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/99—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with other acceptors (1.2.99)
- C12Y102/99006—Carboxylate reductase (1.2.99.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
- C12Y206/01019—4-Aminobutyrate—2-oxoglutarate transaminase (2.6.1.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/08—Transferases for other substituted phosphate groups (2.7.8)
- C12Y207/08007—Holo-[acyl-carrier-protein] synthase (2.7.8.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01015—Glutamate decarboxylase (4.1.1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/265—Micrococcus
- C12R2001/28—Micrococcus glutamicus ; Corynebacterium glutamicum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation, which takes corynebacterium glutamicum as a chassis through a synthetic biological technology, and obtains GBL by introducing exogenous glutamate decarboxylase gene gadB mutant, alcohol dehydrogenase gene yqhD and endogenous or exogenous gamma-aminobutyric acid transaminase gene gabT, realizing the one-step fermentation production of 4-hydroxybutyric acid by fermenting renewable raw materials such as glucose, sucrose and the like by utilizing recombinant microorganisms, and simply heating and decarboxylating fermentation liquor. Further, by introducing a carboxylic acid reductase CAR gene and a phosphopantetheinyl transferase gene sfp into the microorganism, BDO can be produced by directly fermenting glucose, sucrose, or the like with the recombinant microorganism. The invention realizes the direct fermentation production from renewable raw materials to important chemicals GBL and BDO, the production process is clean and safe, the carbon emission is low, and the invention has important industrial application value.
Description
Technical Field
The invention belongs to the technical field of genetic engineering and biological fermentation, and particularly relates to a method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation.
Background
1, 4-Butanediol (BDO) is an important organic chemical and fine chemical raw material, and is widely used for manufacturing various high molecular materials such as polyester, polyurethane, polyether polyol and the like, for example, the BDO is a key monomer for synthesizing engineering plastics such as polybutylene terephthalate (PBT), and is also a key monomer for synthesizing biodegradable materials such as polybutylene succinate (PBS) and PBAT. In recent years, with the advent of plastic-limiting and carbon-neutralizing related policies, the demands of biodegradable materials PBS and PBAT have been developed in a blowout manner, thereby driving the rapid growth of BDO demands in the global market. BDO is also an important precursor for synthesizing chemicals such as tetrahydrofuran, gamma-butyrolactone and the like. Gamma-butyrolactone (GBL) is also an important organic and medical intermediate, has wide application in medicines, pesticides, petrochemical industry and the like, is one of the main components of lithium battery electrolyte, and is also an important raw material for synthesizing chemicals such as 2-pyrrolidone, N-methyl-2-pyrrolidone (NMP), polyvinylpyrrolidone (PVP) and the like.
At present, BDO is synthesized mainly by a chemical method and by taking calcium carbide and the like as raw materials through a complex chemical conversion process, which is an extremely high-energy-consumption process, so that an environment-friendly, energy-saving and consumption-reducing biological method technology is developed, and the BDO produced by directly fermenting renewable biomass raw materials has important industrial application value. The production of GBL is mainly produced by taking BDO as a raw material through a chemical method, and no report on direct synthesis of GBL through a biological method is found at present.
Disclosure of Invention
The invention aims to provide a method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation.
The invention is characterized in that: according to the synthetic biology technology, corynebacterium glutamicum is used as a chassis, exogenous glutamate decarboxylase gene gadB mutant, alcohol dehydrogenase gene yqhD and endogenous or exogenous gamma-aminobutyric acid transaminase gene gabT are enhanced by introducing the chassis, the first realization of one-step fermentation production of 4-hydroxybutyric acid by fermenting renewable raw materials such as glucose, sucrose and the like by utilizing recombinant microorganisms is achieved, and GBL can be obtained by simply heating and dehydrating fermentation liquor. Further, by introducing a carboxylic acid reductase CAR gene and a phosphopantetheinyl transferase gene sfp into the microorganism, BDO can be produced by directly fermenting glucose, sucrose and the like by using the recombinant microorganism.
In order to achieve the object of the present invention, in a first aspect, the present invention provides a recombinant corynebacterium glutamicum constructed by overexpressing a glutamate decarboxylase mutant gene gadB and an alcohol dehydrogenase gene yqhD in corynebacterium glutamicum.
In the invention, the glutamate decarboxylase mutant gene gadB and the alcohol dehydrogenase gene yqhD are derived from escherichia coli; the amino acid sequences encoded by the gene galB and the gene yqhD are respectively shown in SEQ ID NO. 1 and SEQ ID NO. 2.
Further, an endogenous or exogenous gamma-aminobutyric acid transaminase gene gabT is expressed in the recombinant corynebacterium glutamicum.
The gamma-aminobutyric acid transaminase gene gabT can be derived from corynebacterium glutamicum, escherichia coli or pseudomonas putida, and the coded amino acid sequences are respectively shown as SEQ ID NO. 3, SEQ ID NO. 4 or SEQ ID NO. 5.
In a second aspect, the invention provides the use of said recombinant corynebacterium glutamicum in the fermentative production of gamma-butyrolactone.
Further, the recombinant corynebacterium glutamicum is utilized to ferment and produce gamma-butyrolactone by taking an inexpensive carbon source as a raw material.
The inexpensive carbon source may be at least one selected from glucose, sucrose, maltose, cellobiose, and the like.
In a third aspect, the invention provides a corynebacterium glutamicum engineering bacterium, which is constructed by expressing a carboxylic acid reductase CAR gene and a phosphopantetheinyl transferase gene sfp in the recombinant corynebacterium glutamicum.
The CAR gene can be derived from Mycobacterium marinum, nocardia iowensis, mycolicibacterium smegmatis or Mycobacteroides abscessus, and the coded amino acid sequences are respectively shown as SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8 or SEQ ID NO. 9.
The phosphopantetheinyl transferase gene sfp can be derived from bacillus subtilis, and the coded amino acid sequence is shown in SEQ ID NO. 10.
In a fourth aspect, the invention provides an application of the corynebacterium glutamicum engineering bacterium in fermentation production of 1, 4-butanediol.
Further, the corynebacterium glutamicum engineering bacteria are utilized to ferment and produce gamma-butyrolactone by taking a cheap carbon source as a raw material.
The inexpensive carbon source may be at least one selected from glucose, sucrose, maltose, cellobiose, and the like.
In a fifth aspect, the invention provides a glutamic acid decarboxylase mutant, the amino acid sequence of which is shown as SEQ ID NO. 1.
In a sixth aspect, the present invention provides a method for constructing the recombinant corynebacterium glutamicum and the engineering bacterium of corynebacterium glutamicum, wherein the genes can be modified or altered by conventional genetic engineering methods.
By means of the technical scheme, the invention has at least the following advantages and beneficial effects:
the invention mainly uses corynebacterium glutamicum as a chassis by a synthetic biology technology, introduces exogenous glutamate decarboxylase gene gadB mutant, alcohol dehydrogenase gene yqhD and enhanced endogenous or exogenous gamma-aminobutyric acid transaminase gene gabT into the chassis, initially realizes the one-step fermentation production of 4-hydroxybutyric acid by fermenting renewable raw materials such as glucose, sucrose and the like by recombinant microorganisms, and obtains GBL by simply heating and decarboxylating fermentation liquor. Further, by introducing a carboxylic acid reductase CAR gene and a phosphopantetheinyl transferase gene sfp into the microorganism, BDO can be produced by directly fermenting glucose, sucrose and the like by using the recombinant microorganism. The invention realizes the direct fermentation production from renewable raw materials to important chemicals GBL and BDO, the production process is clean and safe, the carbon emission is reduced by more than 60% compared with a chemical method, and the invention has important industrial application value.
Detailed Description
The following examples are illustrative of the invention and are not intended to limit the scope of the invention. Unless otherwise indicated, the examples are in accordance with conventional experimental conditions, such as the molecular cloning laboratory Manual of Sambrook et al (Sambrook J & Russell DW, molecular Cloning: a Laboratory Manual, 2001), or in accordance with the manufacturer's instructions.
EXAMPLE 1 construction method of recombinant Corynebacterium glutamicum producing GBL
No microorganism can naturally synthesize GBL in nature. According to the invention, glutamate produced by corynebacterium glutamicum is firstly converted into gamma-aminobutyric acid by introducing glutamate decarboxylase gabB into corynebacterium glutamicum, the gamma-aminobutyric acid aminotransferase gabT is further converted into 4-hydroxybutyric acid under the action of self or exogenously introduced gamma-aminobutyric acid aminotransferase gabT and exogenously introduced alcohol dehydrogenase yqhD, and the 4-hydroxybutyric acid in fermentation liquor generates GBL under acid catalysis.
The gene fragment of glutamic acid decarboxylase gabB of the escherichia coli is artificially synthesized (the amino acid sequence is shown as SEQ ID NO:1, and the gene sequence is shown as SEQ ID NO: 11). Compared with wild-type glutamate decarboxylase, the glutamate decarboxylase has higher activity under neutral pH conditions. PCR was performed using the gene fragment as a template and the primers of gapB-F (5'-attaagcttgcatgcctgcactttaagaaggagatataccatggataagaagcaagtaacg-3') and gapB-R (5'-ggtatatctccttcttaaagttagtgatcgctgagatatt-3'), to obtain a gapB fragment of about 1.4kb and to perform PCR purification. The genome of Escherichia coli MG1655 was used as a template, and yqhD-F (5'-ctttaagaaggagatataccatgaacaactttaatctgcac-3') and yqhD-R (5'-ggtacccggggatcctctagttagcgggcggcttcgtata-3') were used as primers to carry out PCR, whereby a yqhD fragment of about 1.2kb was obtained and PCR purification was carried out. The pXMJ19 plasmid (purchased from Addgene) was digested with PstI and XbaI, and the purified gabB fragment and yqhD fragment were ligated to pXMJ19 in one step using Gibson Assembly kit (NEB), and the obtained recombinant plasmid was named pXMJ-gabB-yqhD.
PCR was performed using the genome of Corynebacterium glutamicum as a template and the primers gabT_cg-F (5'-ggatccccgggtaccgagctctttaagaaggagatataccgtggaagatctctcataccg-3') and gabT_cg-R (5'-caaaacagccaagctgaattttagcccaccttctggtgcg-3'), to obtain a gabT_cg fragment of about 1.35kb and PCR purification was performed. PCR was performed using the genome of Escherichia coli MG1655 as a template and the primers gabT_ec-F (5'-ggatccccgggtaccgagctctttaagaaggagatataccatgaacagcaataaagagtt-3') and gabT_ec-R (5'-caaaacagccaagctgaattctactgcttcgcctcatcaa-3'), to obtain a gabT_ec fragment of about 1.35kb, and PCR purification was performed. PCR was performed using the genome of Pseudomonas putida as a template and the primers gabT_pp-F (5'-ggatccccgggtaccgagctctttaagaaggagatataccatgagcaagaccaacgaatc-3') and gabT_pp-R (5'-caaaacagccaagctgaatttcaggcaagttcagcgaagc-3') as primers, to obtain a gabT_pp fragment of about 1.35kb and PCR purification was performed. The plasmid pXMJ-gabB-yqhD was digested with KpnI and EcoRI, and the above-purified gabT_cg fragment, gabT_ec fragment and gabT_pp fragment were ligated to pXMJ-gabB-yqhD using the Gibson Assembly kit (NEB), respectively, and the obtained recombinant plasmids were named pXMJ-gabB-yqhD-gabT_cg, pXMJ-gabB-yqhD-gabT_ec and pXMJ-gabB-yqhD-gabT_pp, respectively.
Plasmids pXMJ-gabB-yqhD, pXMJ-gabB-yqhD-gabT_cg, pXMJ-gabB-yqhD-gabT_ec, and pXMJ-gabB-yqhD-gabT_pp were transferred to Corynebacterium glutamicum S9114 by electrotransformation, and recombinant bacteria were obtained by screening on chloramphenicol LB plates containing 10mg/L, and designated S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, and S9114/pXMJ-gabB-yqhD-gabT_pp, respectively. Simultaneously, the pXMJ19 empty plasmid was also transferred into Corynebacterium glutamicum S9114 to obtain control strain S9114/pXMJ.
Example 2 fermentation production of GBL Using inexpensive sugar feedstock
Strains S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ-gabB-yqhD-gabT_pp and a control strain S9114/pXMJ were inoculated into a 5L fermenter to conduct cultivation, the initial volume of the broth was 2L, the fermentation temperature was 30℃and the ventilation amount was 1vvm, the dissolved oxygen value of the fermentation process was maintained at 20% by adjusting the rotation speed, the pH of the broth was controlled at 7.0 by automatic feeding of 25% ammonia, and the fermentation was conducted for 4 hours by adding 0.1mM IPTG and the fermentation time was 48 hours.
The fermentation medium formulation included (g/L): glucose 100, (NH) 4 ) 2 SO 4 20,K 2 HPO 4 1.0,MgSO 4 0.5,MnSO 4 0.2,FeSO 4 0.2, corn steep liquor 20, pyridoxal phosphate 0.01, thiamine hydrochloride 0.001 and chloramphenicol 0.005.
After 48 hours of fermentation, the fermentation was stopped, the pH was adjusted to 0.8 by adding concentrated HCl to the fermentation broth, and the reaction was carried out at room temperature for 24 hours, followed by detection of the strain product by High Performance Liquid Chromatography (HPLC). The strains S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ-gabB-yqhD-gabT_pp can produce GBL of 7.2g/L, 11.3g/L, 14.1g/L, 13.7g/L, respectively, whereas the control strain S9114/pXMJ does not produce GBL. It is demonstrated that the introduction of an artificial route in Corynebacterium glutamicum can successfully achieve efficient production of glucose to GBL.
The carbon source of the fermentation medium is changed from 100g/L glucose to 100g/L sucrose, other components are unchanged, and the fermentation process is kept completely consistent. The strains S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ-gabB-yqhD-gabT_pp can produce GBL of 7.4g/L, 10.2g/L, 13.3g/L, 12.9g/L, respectively, whereas the control strain S9114/pXMJ does not produce GBL. The introduction of an artificial pathway into Corynebacterium glutamicum has been shown to successfully achieve efficient production of sucrose to GBL.
The carbon source of the fermentation medium is changed from 100g/L glucose to molasses (the sucrose content is 100 g/L), other components are unchanged, and the fermentation process is kept completely consistent. The strains S9114/pXMJ-gabB-yqhD, S9114/pXMJ-gabB-yqhD-gabT_cg, S9114/pXMJ-gabB-yqhD-gabT_ec, S9114/pXMJ-gabB-yqhD-gabT_pp can produce GBL of 6.7g/L, 9.9g/L, 12.1g/L, 11.7g/L, respectively, whereas the control strain S9114/pXMJ does not produce GBL. It is demonstrated that the introduction of an artificial route in Corynebacterium glutamicum can successfully achieve efficient production of molasses to GBL.
EXAMPLE 3 construction method of recombinant Corynebacterium glutamicum producing BDO
The strain constructed by the method can efficiently convert low-cost carbon sources such as glucose, sucrose, molasses and the like to produce GBL. The invention further converts the precursor 4-hydroxybutyric acid of GBL into BDO by introducing carboxylic acid reductase, thereby realizing the direct fermentation production of BDO by using cheap carbon sources.
The main function of the phosphopantetheinyl transferase gene sfp (the amino acid sequence is shown as SEQ ID NO:10, the gene sequence is shown as SEQ ID NO: 20) of the artificially synthesized bacillus subtilis is to activate carboxylic acid reductase. PCR was performed using the gene fragment as a template and sfp-F (5'-atcctctagagtcgacctgcactttaagaaggagatataccaatgaaaatttacggcatcta-3') and sfp-R (5'-cagtgccaagcttgcatgcctcaaagtaactcctcgtagg-3') as primers, to obtain an sfp fragment of about 0.7kb, and PCR purification was performed. The pEC-K18mob plasmid (from Addgene) was digested singly with PstI and the sfp fragment obtained by the above purification was ligated in one step to pEC-K18mob using Gibson Assembly kit (NEB), and the recombinant plasmid obtained was designated pEC-sfp.
Car_mm, car_ni, car_ms and Car_ma (the amino acid sequences are shown as SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8 and SEQ ID NO:9 respectively) of carboxylic acid reductase genes Car_mm, car_ni, car_ms and Car_ma derived from Mycobacterium marinum, nocardia iowensis, mycolicibacterium smegmatis and Mycobacteroides abscessus are artificially synthesized, and the nucleotide sequences are shown as SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18 and SEQ ID NO:19 respectively. The plasmid pEC-sfp was digested with EcoRI and KpnI, and the four gene fragments synthesized as described above were inserted into the plasmids pEC-sfp, respectively, and the obtained plasmids were designated pEC-Car_mm-sfp, pEC-Car_ni-sfp, pEC-Car_ms-sfp, pEC-Car_ma-sfp, respectively. Plasmids pEC-Car_mm-sfp, pEC-Car_ni-sfp, pEC-Car_ms-sfp, pEC-Car_ma-sfp were transformed into Corynebacterium glutamicum strain S9114/pXMJ-gabB-yqhD-gabT_ec, respectively, and the obtained recombinant strains were designated as S9114-X-MM, S9114-X-NI, S9114-X-MS, S9114-X-MA, respectively.
Strains S9114-X-MM, S9114-X-NI, S9114-X-MS, S9114-X-MA and control strains S9114/pXMJ-gabB-yqhD-gabT_ec and S9114/pXMJ are inoculated into a 5L fermentation tank for culture, the initial volume of fermentation liquor is 2L, the fermentation temperature is 30 ℃, the ventilation rate is 1vvm, the dissolved oxygen value in the fermentation process is maintained at 20% by adjusting the rotation speed, the pH of the fermentation liquor is controlled to be 7.0 by automatically feeding 25% ammonia water, and 0.1m MIPTG is added for induction during 4h of fermentation, and the fermentation time is 48h.
The fermentation medium formulation included (g/L): glucose 100, (NH) 4 ) 2 SO 4 20,K 2 HPO 4 1.0,MgSO 4 0.5,MnSO 4 0.2,FeSO 4 0.2, corn steep liquor 20, pyridoxal phosphate 0.01, thiamine hydrochloride 0.001 and chloramphenicol 0.005.
Fermentation was stopped after 48 hours of fermentation, and then the products of the strain were detected by High Performance Liquid Chromatography (HPLC). Strains S9114-X-MM, S9114-X-NI, S9114-X-MS, S9114-X-MA produced 7.8g/L, 6.9g/L, 7.2g/L, 7.7g/L BDO, respectively, whereas neither of the control strains S9114/pXMJ-gabB-yqhD-gabT_ec nor S9114/pXMJ produced BDO. It was demonstrated that the introduction of an artificial route in Corynebacterium glutamicum could successfully achieve efficient production of glucose to BDO.
The carbon source of the fermentation medium is changed from 100g/L glucose to 100g/L sucrose, other components are unchanged, and the fermentation process is kept completely consistent. Strains S9114-X-MM, S9114-X-NI, S9114-X-MS, S9114-X-MA produced BDO at 6.4g/L, 6.2g/L, 6.3g/L, 6.9g/L, respectively, whereas neither of the control strains S9114/pXMJ-gabB-yqhD-gabT_ec nor S9114/pXMJ produced BDO. The introduction of an artificial pathway in Corynebacterium glutamicum was shown to successfully achieve efficient production of sucrose to BDO.
The carbon source of the fermentation medium is changed from 100g/L glucose to molasses (the sucrose content is 100 g/L), other components are unchanged, and the fermentation process is kept completely consistent. Strains S9114-X-MM, S9114-X-NI, S9114-X-MS, S9114-X-MA produced BDO at 5.7g/L, 5.9g/L, 5.1g/L, 4.7g/L, respectively, whereas neither of the control strains S9114/pXMJ-gabB-yqhD-gabT_ec nor S9114/pXMJ produced BDO. It was demonstrated that the introduction of an artificial route in Corynebacterium glutamicum could successfully achieve efficient production of molasses to BDO.
While the invention has been described in detail in the foregoing general description and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that modifications and improvements can be made thereto. Accordingly, such modifications or improvements may be made without departing from the spirit of the invention and are intended to be within the scope of the invention as claimed.
Claims (10)
1. The recombinant corynebacterium glutamicum is characterized in that the recombinant corynebacterium glutamicum is obtained by over-expressing a glutamate decarboxylase mutant gene gadB and an alcohol dehydrogenase gene yqhD in the corynebacterium glutamicum;
the glutamate decarboxylase mutant gene gadB and the alcohol dehydrogenase gene yqhD are derived from escherichia coli; the amino acid sequences encoded by the gene galB and the gene yqhD are respectively shown in SEQ ID NO. 1 and SEQ ID NO. 2.
2. The recombinant corynebacterium glutamicum according to claim 1, wherein an endogenous or exogenous gamma-aminobutyric acid transaminase gene gabT is further expressed in the recombinant corynebacterium glutamicum.
3. The recombinant corynebacterium glutamicum according to claim 2, wherein said gamma-aminobutyric acid transaminase gene gabT is derived from corynebacterium glutamicum, escherichia coli or pseudomonas putida, and the amino acid sequences encoded by the gene gabT are shown in SEQ ID NO. 3, SEQ ID NO. 4 or SEQ ID NO. 5, respectively.
4. Use of a recombinant corynebacterium glutamicum according to any one of claims 1 to 3 for the fermentative production of gamma-butyrolactone.
5. The use according to claim 4, wherein the gamma-butyrolactone is produced by fermentation using an inexpensive carbon source as a starting material;
the cheap carbon source is at least one selected from glucose, sucrose, maltose and cellobiose.
6. The corynebacterium glutamicum engineering bacterium is characterized in that the engineering bacterium is obtained by constructing a carboxylic acid reductase CAR gene and a phosphopantetheinyl transferase gene sfp expressed in the recombinant corynebacterium glutamicum according to any one of claims 1 to 3.
7. The engineering bacterium according to claim 6, wherein the carboxylic acid reductase CAR gene is derived from Mycobacterium marinum, nocardia iowensis, mycolicibacterium smegmatis or Mycobacteroides abscessus, and the amino acid sequences encoded by the carboxylic acid reductase CAR gene are shown in SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8 or SEQ ID NO. 9, respectively; and/or
The phosphopantetheinyl transferase gene sfp is derived from bacillus subtilis, and the coded amino acid sequence is shown in SEQ ID NO. 10.
8. The use of the engineering bacteria of claim 6 or 7 in the fermentative production of 1, 4-butanediol.
9. The use according to claim 8, characterized in that 1, 4-butanediol is produced by fermentation starting from an inexpensive carbon source;
the cheap carbon source is at least one selected from glucose, sucrose, maltose and cellobiose.
10. The glutamic acid decarboxylase mutant is characterized in that the amino acid sequence is shown as SEQ ID NO. 1.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211176997.7A CN116083329A (en) | 2022-09-26 | 2022-09-26 | Method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation |
PCT/CN2023/114599 WO2024066822A1 (en) | 2022-09-26 | 2023-08-24 | METHOD FOR PRODUCING γ-BUTYROLACTONE OR 1,4-BUTANEDIOL BY FERMENTATION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211176997.7A CN116083329A (en) | 2022-09-26 | 2022-09-26 | Method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116083329A true CN116083329A (en) | 2023-05-09 |
Family
ID=86199810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211176997.7A Pending CN116083329A (en) | 2022-09-26 | 2022-09-26 | Method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN116083329A (en) |
WO (1) | WO2024066822A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117089507A (en) * | 2023-09-28 | 2023-11-21 | 北京化工大学 | Escherichia coli genetically engineered bacterium for synthesizing 1, 4-butanediol by using cheap carbon source and application thereof |
WO2024066822A1 (en) * | 2022-09-26 | 2024-04-04 | 北京绿色康成生物技术有限公司 | METHOD FOR PRODUCING γ-BUTYROLACTONE OR 1,4-BUTANEDIOL BY FERMENTATION |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101668861A (en) * | 2007-03-16 | 2010-03-10 | 基因组股份公司 | compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US20100112654A1 (en) * | 2008-09-10 | 2010-05-06 | Burk Mark J | Microorganisms for the production of 1,4-butanediol |
US20110014669A1 (en) * | 2009-01-23 | 2011-01-20 | Microbia, Inc. | Production of 1,4 Butanediol in a Microorganism |
US20110129899A1 (en) * | 2009-10-13 | 2011-06-02 | Robert Haselbeck | Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-coa, putrescine and related compounds, and methods related thereto |
CN102498215A (en) * | 2009-06-04 | 2012-06-13 | 基因组股份公司 | Microorganisms for the production of 1,4-butanediol and related methods |
CN102781926A (en) * | 2010-02-11 | 2012-11-14 | 梅塔玻利克斯公司 | Process for gamma-butyrolactone production |
US20140030779A1 (en) * | 2012-06-04 | 2014-01-30 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
US20140170714A1 (en) * | 2011-08-10 | 2014-06-19 | Metabolix, Inc. | Post process purification for gamma-butyrolactone production |
US20140371417A1 (en) * | 2013-04-26 | 2014-12-18 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
CN105647912A (en) * | 2014-12-01 | 2016-06-08 | 清华大学 | Acid resistance expression cassette and screening method thereof |
US20160264978A1 (en) * | 2011-06-22 | 2016-09-15 | Genomatica, Inc. | Microorganisms for producing 1,4-butanediol and methods related thereto |
US20190276863A1 (en) * | 2009-11-25 | 2019-09-12 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101381002B1 (en) * | 2012-04-23 | 2014-04-04 | 동국대학교 산학협력단 | Method for gamma-aminobutyric acid with glycerol as substrate by biotransformation process |
BR112016029375A2 (en) * | 2014-06-16 | 2017-10-17 | Invista Tech Sarl | methods, reagents and cells to biosynthesize compounds |
US9920339B2 (en) * | 2014-06-16 | 2018-03-20 | Invista North America S.A.R.L. | Methods, reagents and cells for biosynthesizing compounds |
CN116083329A (en) * | 2022-09-26 | 2023-05-09 | 北京绿色康成生物技术有限公司 | Method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation |
-
2022
- 2022-09-26 CN CN202211176997.7A patent/CN116083329A/en active Pending
-
2023
- 2023-08-24 WO PCT/CN2023/114599 patent/WO2024066822A1/en unknown
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101668861A (en) * | 2007-03-16 | 2010-03-10 | 基因组股份公司 | compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US20100112654A1 (en) * | 2008-09-10 | 2010-05-06 | Burk Mark J | Microorganisms for the production of 1,4-butanediol |
US20110014669A1 (en) * | 2009-01-23 | 2011-01-20 | Microbia, Inc. | Production of 1,4 Butanediol in a Microorganism |
CN102498215A (en) * | 2009-06-04 | 2012-06-13 | 基因组股份公司 | Microorganisms for the production of 1,4-butanediol and related methods |
CN113528417A (en) * | 2009-06-04 | 2021-10-22 | 基因组股份公司 | Microorganisms for producing 1, 4-butanediol and related methods |
US20110129899A1 (en) * | 2009-10-13 | 2011-06-02 | Robert Haselbeck | Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-coa, putrescine and related compounds, and methods related thereto |
US20190276863A1 (en) * | 2009-11-25 | 2019-09-12 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
CN102781926A (en) * | 2010-02-11 | 2012-11-14 | 梅塔玻利克斯公司 | Process for gamma-butyrolactone production |
US20160264978A1 (en) * | 2011-06-22 | 2016-09-15 | Genomatica, Inc. | Microorganisms for producing 1,4-butanediol and methods related thereto |
US20140170714A1 (en) * | 2011-08-10 | 2014-06-19 | Metabolix, Inc. | Post process purification for gamma-butyrolactone production |
US20140030779A1 (en) * | 2012-06-04 | 2014-01-30 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
US20140371417A1 (en) * | 2013-04-26 | 2014-12-18 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
CN105647912A (en) * | 2014-12-01 | 2016-06-08 | 清华大学 | Acid resistance expression cassette and screening method thereof |
Non-Patent Citations (12)
Title |
---|
JAE WOONG CHOI等: "Enhanced production of gamma-aminobutyrate(GABA) in recombinant Corynebacterium glutamicum by expressing glutamate decarboxylase active in expanded pH range", 《MICROBIAL CELL FACTORIES》, vol. 14, no. 21, 15 February 2015 (2015-02-15), pages 2, XP021211597, DOI: 10.1186/s12934-015-0205-9 * |
JIAN WANG等: "Bacterial synthesis of C3-C5 diols via extending amino acid catabolism", 《PNAS》, vol. 117, no. 32, 27 July 2020 (2020-07-27), pages 19160 - 19163 * |
无: "GenBank: HBP9016664.1", 《GENBANK》, 1 February 2022 (2022-02-01) * |
无: "GenBank: PNG88356.1", 《GENBANK》, 18 January 2018 (2018-01-18) * |
无: "NCBI Reference Sequence: WP_001058802.1", 《GENBANK》, 13 March 2021 (2021-03-13) * |
无: "NCBI Reference Sequence: WP_001087611.1", 《GENBANK》, 16 December 2020 (2020-12-16) * |
无: "NCBI Reference Sequence:005082584.1", 《GENBANK》, 7 January 2020 (2020-01-07) * |
无: "NCBI Reference Sequence:WP_ 011013682.1", 《GENBANK》, 25 May 2020 (2020-05-25) * |
无: "NCBI Reference Sequence:WP_003234549.1", 《GENBANK》, 10 July 2019 (2019-07-10) * |
无: "NCBI Reference Sequence:WP_011730755.1", 《GENBANK》, 6 January 2020 (2020-01-06) * |
无: "NCBI Reference Sequence:WP_012393886.1", 《GENBANK》, 15 June 2019 (2019-06-15) * |
无: "UniProtKB/Swiss-Prot:Q6RKB1.1", 《GENBANK》, 25 May 2022 (2022-05-25) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024066822A1 (en) * | 2022-09-26 | 2024-04-04 | 北京绿色康成生物技术有限公司 | METHOD FOR PRODUCING γ-BUTYROLACTONE OR 1,4-BUTANEDIOL BY FERMENTATION |
CN117089507A (en) * | 2023-09-28 | 2023-11-21 | 北京化工大学 | Escherichia coli genetically engineered bacterium for synthesizing 1, 4-butanediol by using cheap carbon source and application thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2024066822A1 (en) | 2024-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4582228B2 (en) | polyester | |
EP2201115B1 (en) | Mutants having capability to produce 1,4-butanediol and method for preparing 1,4-butanediol using the same | |
EP1760143B1 (en) | Succinic acid-producing bacterium and process for producing succinic acid | |
JP5180060B2 (en) | Organic acid producing bacteria and method for producing organic acid | |
JP4575086B2 (en) | Method for producing succinic acid | |
CN116083329A (en) | Method for producing gamma-butyrolactone or 1, 4-butanediol by fermentation | |
WO2005113745A1 (en) | Succinic acid-producing bacterium and process for producing succinic acid | |
US11053520B2 (en) | Recombinant Corynebacterium glutamicum strain for producing glutaric acid and method of producing glutaric acid by using same | |
KR100511734B1 (en) | Method for producing optically active compound | |
US10287571B2 (en) | Genetically modified microorganism for improved production of fine chemicals on sucrose | |
US10947547B2 (en) | Recombinant microorganism having enhanced 2,3-butanediol producing ability and method for producing 2,3-butanediol using the same | |
CN112063572A (en) | Recombinant escherichia coli for high yield of O-acetyl-L-homoserine and application thereof | |
JP3151075B2 (en) | Alanine production method | |
EP2904104B1 (en) | Recombinant microorganisms for producing organic acids | |
US10760104B2 (en) | Method of producing D-xylonate and coryneform bacterium | |
CN111411128B (en) | Whole cell biocatalysis method for producing alpha, omega-dicarboxylic acid and application thereof | |
JP5602982B2 (en) | Method for producing succinic acid | |
KR102129379B1 (en) | A recombinant microorganism into which a high activity malate dehydrogenase for producing succinic acid and a method for producing succinic acid using the same | |
CN116396914A (en) | Method for producing 3-hydroxy propionic acid and acrylic acid by fermentation | |
WO2005045049A1 (en) | Method for producing organic acid ammonium solution | |
DE10312775B4 (en) | Method and microorganism for the microbial production of L-alanine | |
KR100957772B1 (en) | Mutants Having a Producing Ability of 4?hydroxybutyrate and Method for Preparing 4HB Using the Same | |
KR100447532B1 (en) | (R)-Hydroxycarboxylic Acid Producing Recombinant Microorganism and Process for Preparing (R)-Hydroxycarboxylic Acid Using the Same | |
JP7158107B2 (en) | Method for producing organic compounds | |
WO2016030373A1 (en) | Modified microorganism for improved production of fine chemicals on sucrose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |